Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma

Clinical trial NCT02278887 · COMPLETED

Trial details

NCT number: NCT02278887
Sponsor: The Netherlands Cancer Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2014-09-23
Primary completion: 2022-09-01
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.